Published in Vaccine Weekly, December 23rd, 2009
"A new purified, inactivated JEV vaccine (IC51, Ixiaro ®) has been developed. Since early 2009, the vaccine has been licensed in Australia, the USA and Europe. A series of successful Phase III studies has been published. indicate a very good safety and efficacy profile. The vaccine promises to become a modern approach to active immunization against Japanese encephalitis," wrote T. Jelinek and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly